β Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (464) π οΈ Industry Q&A (98) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ§© Revenue Segmentation by Product
Switch to Location
Fiscal year | Segment | Value |
---|---|---|
2024 | Biopharma Segment | 8.39B |
2023 | Biopharma Segment | 7.58B |
2022 | Biopharma Segment | 8.54B |
2021 | Biopharma Segment | 7.65B |
2021 | Total Biosimilars | 2.34B |
2020 | Biopharma Segment | 5.42B |
2020 | Total Biosimilars | 1.53B |
2019 | Biopharma Segment | 44.45B |
2018 | Essential Health Segment | 10.54B |

π° Explore more revenue segmentation data for Pfizer!
Sign up for free or log inπ₯ Free eBook for new users: "The Checklist Value Investor β A Smarter Way to Pick Stocks"